CD44 and ovarian carcinoma: Interestingly, a recent study demonstrated that ovarian cancer-derived exosomes could transfer CD44 to human peritoneal mesothelial cells (HPMCs) and induce morphologic change in HPMCs to a mesenchymal, spindle phenotype.